utidelone injection
utidelone injection is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Clinical Trials (6)
Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6